BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

471 related articles for article (PubMed ID: 12192935)

  • 1. [Role of nutritional support in the treatment of enteric fistulas].
    Amodeo C; Caglià P; Gandolfo L; Veroux M; Brancato G; Donati M
    Chir Ital; 2002; 54(3):379-83. PubMed ID: 12192935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Parenteral and enteral nutrition and the enterocutaneous fistula treatment. II. Factors influencing the outcome of treatment.
    Dárdai E; Pirityi S; Nagy L
    Acta Chir Hung; 1991; 32(4):305-18. PubMed ID: 1844622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parenteral and enteral nutrition and the enterocutaneous fistula treatment. I. Investigations on fistula output, nutritional status complications.
    Dárdai E; Pirityi S; Nagy L
    Acta Chir Hung; 1991; 32(4):287-303. PubMed ID: 1844621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. One hundred and fourteen fistulas of the gastrointestinal tract treated with total parenteral nutrition.
    Rose D; Yarborough MF; Canizaro PC; Lowry SF
    Surg Gynecol Obstet; 1986 Oct; 163(4):345-50. PubMed ID: 3094180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the effectiveness of octreotide in the conservative treatment of postoperative enterocutaneous fistulas.
    Alivizatos V; Felekis D; Zorbalas A
    Hepatogastroenterology; 2002; 49(46):1010-2. PubMed ID: 12143189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Total parenteral nutrition in patients with enterocutaneous intestinal fistulas].
    Dardai E; Erdös L; Stefanics J
    Zentralbl Chir; 1983; 108(2):77-86. PubMed ID: 6405557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The management of enterocutaneous fistulas with parenteral hyperalimentation.
    Alhan E; Calik A; Kucuktulu U
    Z Gastroenterol; 1993 Nov; 31(11):657-60. PubMed ID: 8291277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of fistulas of the gastrointestinal tract with total parenteral nutrition and octreotide in patients with carcinoma.
    Spiliotis J; Briand D; Gouttebel MC; Astre C; Louer B; Saint-Aubert B; Kalfarentzos F; Androulakis J; Joyeux H
    Surg Gynecol Obstet; 1993 Jun; 176(6):575-80. PubMed ID: 8322132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fistuloclysis can successfully replace parenteral feeding in the nutritional support of patients with enterocutaneous fistula.
    Teubner A; Morrison K; Ravishankar HR; Anderson ID; Scott NA; Carlson GL
    Br J Surg; 2004 May; 91(5):625-31. PubMed ID: 15122616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Parenteral hyperalimentation in the treatment of esophageal, gastric and intestinal fistulas (author's transl)].
    Launois B; Roumane H; Campion JP; Malledant Y; Trebuchet G
    Sem Hop; 1979 May 18-25; 55(19-20):998-1002. PubMed ID: 227101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New alternatives for the treatment of fistulas in Crohn's disease.
    Skvarilová M; Nicáková R; Axmann K
    Acta Univ Palacki Olomuc Fac Med; 1994; 138():29-31. PubMed ID: 8714089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survival rate and prognostic factors in patients with intestinal failure.
    Vantini I; Benini L; Bonfante F; Talamini G; Sembenini C; Chiarioni G; Maragnolli O; Benini F; Capra F
    Dig Liver Dis; 2004 Jan; 36(1):46-55. PubMed ID: 14971815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Postoperative complications in gastrointestinal cancer patients: the joint role of the nutritional status and the nutritional support.
    Bozzetti F; Gianotti L; Braga M; Di Carlo V; Mariani L
    Clin Nutr; 2007 Dec; 26(6):698-709. PubMed ID: 17683831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postoperative duodenal fistulas. A report of 23 cases with emphasis on the surgical treatment by the Roux-en-Y operation.
    De Backer A; Fetelian D; Carpentier Y; Willems G
    Acta Chir Belg; 1985; 85(3):185-91. PubMed ID: 3929511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Parenteral or enteral hyperalimentation in the treatment of enterocutaneous fistulas?].
    Wolf G; Steindorfer P; Pierer G
    Zentralbl Chir; 1988; 113(15):973-87. PubMed ID: 3140530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary conservative management of external small-bowel fistulas. Changing composition of fistula series?
    Rinsema W; Gouma DJ; von Meyenfeldt MF; van der Linden CJ; Soeters PB
    Acta Chir Scand; 1990; 156(6-7):457-62. PubMed ID: 2114721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effects of enteral nutrition on intestinal intraepithelial lymphocytes of intestinal mucosal and the barrier of mucus in patients with stomal type enteric fistula].
    Hong SJ; Gu GS; Ren JA; Li N; Li JS
    Zhonghua Wei Chang Wai Ke Za Zhi; 2006 Nov; 9(6):527-9. PubMed ID: 17143802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Somatostatin and/or total parenteral nutrition for the treatment of intestinal fistulas].
    Planas M; Porta I; Anglés R; Baena JA; Serra J; Padró JB
    Rev Esp Enferm Dig; 1990 Dec; 78(6):345-7. PubMed ID: 1982616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prevention of infectious postoperative complications in Crohn's disease].
    Ficari F; Bagnoli S; Tonelli F
    Chir Ital; 1995; 47(5):9-14. PubMed ID: 9162602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of enterocutaneous fistulas with TPN and somatostatin, compared with patients who received TPN only.
    Spiliotis J; Vagenas K; Panagopoulos K; Kalfarentzos F
    Br J Clin Pract; 1990 Dec; 44(12):616-8. PubMed ID: 1983231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.